As of 2024-12-12, the Relative Valuation of Tandem Diabetes Care Inc (TNDM) is (62.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.52 USD, the upside of Tandem Diabetes Care Inc based on Relative Valuation is -280.3%.
The range of the Relative Valuation is (61.73) - (63.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.0x - 38.6x | 34.8x |
| Forward P/E multiples | 28.5x - 33.0x | 29.8x |
| Fair Price | (61.73) - (63.62) | (62.25) |
| Upside | -278.8% - -284.3% | -280.3% |
| Date | P/E |
| 2024-12-09 | -16.63 |
| 2024-12-06 | -15.60 |
| 2024-12-05 | -15.68 |
| 2024-12-04 | -16.72 |
| 2024-12-03 | -17.29 |
| 2024-12-02 | -16.84 |
| 2024-11-29 | -15.87 |
| 2024-11-27 | -16.17 |
| 2024-11-26 | -15.56 |
| 2024-11-25 | -15.76 |
| 2024-11-22 | -15.96 |
| 2024-11-21 | -15.92 |
| 2024-11-20 | -15.62 |
| 2024-11-19 | -14.44 |
| 2024-11-18 | -14.90 |
| 2024-11-15 | -14.16 |
| 2024-11-14 | -14.81 |
| 2024-11-13 | -15.37 |
| 2024-11-12 | -16.11 |
| 2024-11-11 | -16.25 |
| 2024-11-08 | -15.85 |
| 2024-11-07 | -17.26 |
| 2024-11-06 | -17.74 |
| 2024-11-05 | -17.15 |
| 2024-11-04 | -17.02 |
| 2024-11-01 | -16.53 |
| 2024-10-31 | -16.25 |
| 2024-10-30 | -16.76 |
| 2024-10-29 | -17.06 |
| 2024-10-28 | -16.97 |
| 2024-10-25 | -16.24 |
| 2024-10-24 | -16.45 |
| 2024-10-23 | -16.66 |
| 2024-10-22 | -17.38 |
| 2024-10-21 | -17.67 |
| 2024-10-18 | -18.31 |
| 2024-10-17 | -18.03 |
| 2024-10-16 | -19.43 |
| 2024-10-15 | -19.48 |
| 2024-10-14 | -19.35 |
| 2024-10-11 | -19.20 |
| 2024-10-10 | -18.72 |
| 2024-10-09 | -20.27 |
| 2024-10-08 | -20.65 |
| 2024-10-07 | -21.64 |
| 2024-10-04 | -21.64 |
| 2024-10-03 | -20.96 |
| 2024-10-02 | -21.33 |
| 2024-10-01 | -21.28 |
| 2024-09-30 | -21.97 |